MM
Manish Mehrotra
About Manish Mehrotra
Data last updated:
Manish Mehrotra is a Director at Mutual Pharma Private Limited (since 2013). The companies operate in Healthcare. Mutual Pharma Private Limited reported revenue of ₹1.96 Cr (FY 2017). Earlier, Manish Mehrotra was an Additional Director at Garvit Innovative Promoters Limited (from 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mutual Pharma Private Limited U51909HR2012PTC046908 | Director | 16 Aug 2013 | 2012 | ₹1.96 Cr (FY 2017) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Garvit Innovative Promoters Limited U70102UP2010PLC041399 | Additional Director | 21 Jan 2019 | 2010 | ₹1.56 Cr (FY 2018) | Under Cirp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manish Mehrotra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sharad Mehrotra | 05318392 | Mutual Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manish Mehrotra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manish Mehrotra
Manish Mehrotra currently holds 1 directorship: Mutual Pharma Private Limited (Director, since 16 Aug 2013, revenue ₹1.96 Cr (FY 2017)).
Manish Mehrotra was first appointed on 16 Aug 2013 as Director at Mutual Pharma Private Limited. The most recent appointment on record is 21 Jan 2019 at Garvit Innovative Promoters Limited.
Manish Mehrotra held 1 earlier board appointment: Garvit Innovative Promoters Limited (Additional Director, from 21 Jan 2019).
The current boards of Manish Mehrotra's companies include Sharad Mehrotra (Mutual Pharma Private Limited).